Healthcare providers have always relied on Lexicomp’s clinical information to provide them with answers to questions about drug interactions. It is important that providers have a trusted resource to find information about the potential, risk, and mechanism of drug and natural product interactions, and methods to manage these risks in their patient’s regimen. The key to Lexicomp’s drug interaction content comes from a strong knowledge base of understanding the pharmacokinetics of drug interactions and a scientific approach to predicting interactions. Lexicomp’s comprehensive suite of clinical information concerning drug-drug and drug-food interactions is one of the key reasons why EMR vendors use Lexi-Data for clinical decision support to meet Meaningful Use certification requirements.
Lexi-Data’s drug-drug interaction API provides developers many opportunities to customize the display of drug interaction information, offers a severity rating for each interaction, an “advice” header, and a textual description of the significance, nature, and management of the interaction. Lexi-Data also helps manage alert fatigue with the ability to customize interaction alerts for different views.
Lexicomp will be exhibiting at HIMSS 2012 in Las Vegas from February 20 - 24. Stop by for a visit at Booth #5134 and learn more about the preferred choice of drug information databases!
Lexicomp will be attending HIMSS 2012 in Las Vegas. This will be a great opportunity for any EMR, Hospital, or Consumer Health Site to visit booth #5134 and learn about our solutions for implementing decision support for drug interactions, duplicate therapy, drug allergies, and dose range checking, as well as drug databases, and patient education information for consumers.
At HIMSS 2012 there will be live demonstrations showing how our drug databases can be implemented and customized to meet the various specific needs of EMR vendors. Stop by and see us if you are a current customer or are looking to implement drug information or clinical decision support into your application.
Lexi-Data, Lexicomp's clinical decision support database is perfect for EMR vendors looking to meet a number of Meaningful Use requirements:
Allows for specific clinical decision support functions, including drug-drug and drug-allergy interaction checking
Has consumer-facing patient education materials
Is compliant with the RxNorm
Include comprehensives reference information for the US including drug generic name, drug brand name, drug classifications, and eventually clinical dosage guidelines for calculating pediatric and adult doses
Lexicomp will be exhibiting at HIMSS 2012 in Las Vegas, from February 20 - 24. Stop by for a visit at Booth #5134 and learn more about the choices you have in drug information databases!
Are you developing EMRs and practice management systemswhere speed to market is critical?One of the modules of such systems is the inclusion of drug information.Since this is neither the expertise of your developers nor your content people,it is important to identify the preferred drug information provider early in the process.Fourcriteria are critical in making this decision.First,quality of information.Second,flexibility of design and APIs.Third,simplicity of data structure.Fourth,and very important,customer support during the development period and after release. More and more EMRs are now using Lexicompdrug information as part of their offering.And there is a reason for that.
Lexi-Data is the foundation of Lexicomp's clinical decision support architecture is quickly becoming the standard for when companies need an up-to-date comprehensive drug database. This product provides patient specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, supports Surescripts Certification, Drug Classifications, dose range checking (adult and pediatric), Patient Education, Pediatric and neonatal drug interactions and more.
ePrescribing is offered as a way to prevent medication errors that arise due to difficulties in reading or understanding handwritten prescriptions. ePrescribing could also reduce adverse drug events (ADEs) by making information such as drug interactions and contraindications available to prescribers at the time they are preparing a prescription.
Lexi-Data is the foundation of Lexicomp's clinical decision support architecture is quickly becoming the standard for when companies need an up-to-date comprehensive drug database. This product provides patient specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, supports Surescripts Certification, Drug Classifications, dose range checking (adult and pediatric), Patient Education, and more.
Lexicomp is increasingly the preferred choice of EHR and EMR vendors for pharmaceutical and clinical information. What benefits do they deliver for developers?
Meaningful Use support: Including drug-drug and drug-allergy interaction checking
Superior customer service: Every customer receives personal service, no matter the size
Advanced filtering options: A unique system of complex filters allows users to target Black Boxed Warnings to particular users and circumstances
Trusted content and name: Thousands of physicians, pharmacists, nurses, dentists, and other clinicians buy information direct from Lexicomp because they trust it
Full support for eprescribing: Customers have used Leicomp's clinical decision support to create their own e-prescribing modules for EMRs and EHRs
These are just five of the many benefits that Lexicomp customers enjoy. To find out more, request a demonstration today!
Lexicomp's drug interaction database has grown by leaps and bounds over the past few years. Now used by hundreds of EMR, EHR, HIS and other healthcare vendors, it is the information behind medication reference and clinical decision support for tens of thousands of physicians.
What makes Lexicomp the preferred choice?
Easier implementation when compared to other data sources
Superior customer service for all customers, regardless of size
Full support of Meaningful Use Stage 1 clinical decision support requirements
New innovative features like patient education in multiple languages
Flexible delivery, including robust APIs and web services
More and more healthcare information vendors are discovering that Lexicomp can save them development time, making the road to certification and market faster and smoother. Find out today if Lexicomp can do the same for you!
Lexicomp is the seller of Lexi-Data, a transactional drug interaction database for EHR vendors, EMR vendors, HIS systems, ePrescribers, PMS systems, consumer websites, patient portals, and more. Hundreds of Lexi-Data customers are integrating Lexicomp's referential and clinical decision support information into their own systems and products.
Comprehensive data covers all decision support Meaningful Use requirements:
Compatible with required standards like RxNorm
Supports drug-drug and drug-allergy interaction checking
All data necessary for ePrescribing and CPOE
Additional functionality like dose range checking
Fastest and easiest integration gets you to market faster:
Easy-to-use APIs and web services -- you choose which you want
Superior one-on-one customer service
Most intuitive data structure and fastest implementation
New features set you apart from the competition:
Black Box Warning filters to alleviate clinician alert fatigue
Patient education available in 19 languages
Click the links on this page to find out more about Lexi-Data now!
Alert fatigue is related to the barrage of messages provided clinical decision support systems which can overwhelm a provider and cause them to ignore messages. The alerts, while found to be helpful in some cases, can result in a type of "fatigue" whereby the provider, after receiving too many alerts, begins to ignore and/or override the alerts. Receiving too many alerts can result in slowing the provider down rendering the alert useless.
One of the key reasons that clinicians are frustrated with decision support related to drug interaction software is the potential for this alert fatigue. Clinicans do not want to be messaged regarding dosage precautions related to an interaction which has already been recognized and addressed. It is particularly important in the era of electronic prescribing to engineer systems which can present the appropriate information to the appropriate person. Systems need to recognize whether an individual has previously addressed the issue, rather than simply blindly alerting to the presence of two medications within the medicine list. A collaborative effort between drug database providers and application vendors is needed, and discussions to improve the quality of alerts, while decreasing the quantity, are moving forward. These will greatly improve satisfaction with these tools.
Not all clinical information is structured the same! The more detail that your medication and clinical information vendor provides about crucial alerts, the easier it is for you to implement customization for your users. If every alert looks the same (which is true of what many vendors provide!), then that means that your users will have to go through them all one by one, setting their preferences on warnings and dosage precautions by hand. Then they have to keep their settings up to date as new alerts are added. That's not user friendly design!
By contrast, Lexicomp's implementation of Black Box Warnings (also called Black Boxed Warnings) gives a great deal of flexibility to developers to allow for multi-dimensional customization. Each warning contains information about which clinician the alert is intended for, how severe the alert is, and whether the alert applies only to patients with specific conditions (e.g., pregnancy).
Win customer loyalty by automating alert customization! This way, you can automate much of the customization without having to ask for input from every individual user. You can simply have the system hide alerts intended for nurses from pharmacists, and vice-versa. Likewise, you can make your system intelligent enough to hide alerts related to pregnancy from male patients. This is the kind of smart implementation that users are looking for to help them aviod alert fatigue and become more efficient and effective clinicians. Talk to Lexicomp today to learn more!
Does your EHR meet the certification requirements established by ONC? Lexicomp can help by providing your system key clinical decision support data required for certification. As an integrated component of your EHR, our transactional drug data and reference information support the following Stage 1 meaningful use and certification criteria from ONC's Final Rule.
Lexi-Data is the foundation of Lexicomp's clinical decision support architecture. This product provides clinical decision alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, Drug Classifications, dose range checking (adult and pediatric) and more.
It is estimated that each year some 530,000 adverse drug events take place among Medicare beneficiaries alone because of drugs negatively interacting with other drugs the patient is already taking, or insufficient information about the patient’s medical history. The Institute of Medicine (IOM) reported last year that more than 1.5 million Americans are injured annually by drug errors in hospitals, nursing homes and doctor’s offices. These negative drug events may require costly interventions in order to stabilize the patient, including hospitalization.
Electronic prescribing (eRx) has been recognized as an important step in moving health care from a paper-based legacy to a new electronic platform. The use of ePrescribing has been incentivized by the federal government, specifically via the Centers for Medicare and Medicaid Services (CMS).
Lexi-Data is the foundation of Lexi-Comp's clinical decision support architecture. This product provides patient specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, Drug Classifications, dose range checking (adult and pediatric) and more.
I am reposting comments I made several months ago. Why? Because it is very important to build an EMR with the best pediatric dosing information possible. The implication are clear. So, if you are in the midst of building a new EMR or just want to include a link from your EHR over to Lexicomp Online's Pediatric Dose Range Checking, I would suggest reading this.
It might seem like an easy question, but the answer is neither obvious nor unimportant. Both pediatric and neonatal dose range calculators are receiving more focus and attention. This is serious business, with serious consequences. Last week, Matt Bennardo wrote a blog posting wherehe cited astudy by Practice Fusion, where it has been shown that EHR's are having a real impact on the decrease in infant mortality. This is great news for those EHR's that have elected to use better dose range checking calculators.
As I said in a post last week. "Allpediatric dosage calculatorsare not created equally. As Matt goes on to say, "But luckily there are drug information vendors like Lexicomp that understand there is a vast world of difference between adults and children -- and often between older children and neonates. Lexicomp's drug information is trusted by dozens of EHR vendors to guide clinicians in prescribing, fulfilling, and administering drugs to patients of all types -- including children."
Lexicomp provides both "machine readable" transactional information (geared towards specific populations) for use in clinical decision support, as well as "human readable" reference materials for clinicians and patients. Even Lexicomp's patient education leaflets are written with either adult or pediatric patients in mind.
If you are developing an EMR or looking to improve an EHR or HIS system, I would suggest reaching out toLexicompfor some suggestions. Lexicomp is known for its pediatric and neonatal drug information.
EMRs and EHRs have already greatly impacted the way clinical decisions are made. Safer and better decisions are possible, if there is quality and relaible drug data at the heart of all clinical decision support systems. To make their quality drug data even better, Lexi-Data has introduced a new structure which allows for the customization of Black Boxed Warning. These warnings act to reduce alert fatigue, while at the same time delivering warnings to the people who needs them most. Such new technologies will make all areas of clinical decision support better, contact Lexicomp today to see what they can offer you.
One of the most common comments I hear from users of Electronic Medical Records (EMR) systems is associated with “alert fatigue” from unwelcome drug interaction notifications. Many users tell me that they are flooded with unavoidable but unnecessary alerts that interrupt their workflow, decrease productivity, and make the important alerts harder to see. Clinicians find themselves clicking through the alerts as quickly as possible which defeats the purpose of clinical decision support.
In today's fast-paced healthcare industry, electronic health record (EHR) and other healthcare information system vendors need smart, current drug data that will enable their systems to drive patient safety and improve healthcare -- without generating a flood of annoying alerts that will only be ignored. Lexicomp has recently included new functionality that can alert users with the appropriate Black Box Warning where appropriate in the current workflow.
In the most simple terms, an FDA Black Box Warning is the strongest warning that the US Food and Drug Administration (FDA) puts on a drug. It means that you should pay close attention to the drug's usage because there are some potentially extremely harmful or dangerous threats to your health that the already FDA approved drugs could pose.
The other side of the coin, however, is that an FDA Black Box Warning means that despite the FDA's knowledge of these harmful, serious and sometimes deadly side effects that they are still leaving the FDA approved drug on the market for you to be able to take and potentially experience these harmful side effects. In theory, these FDA Black Box Warnings are designed for both the doctor who is prescribing the drug to be aware of the problems and for you as the consumer to be more aware.
The warning is placed in a prominent 'black box' on the package insert of an FDA approved drug so that people and their doctors can be more aware of it, but few doctors ever see the pill bottles and the vast majority of consumers realistically aren't going to go through the amazingly large amount of technical and medically detailed information on a package insert. This can lead to doctors note being aware of a serious alert which can have serious consequences. With Lexicomp’s inclusions of Black Box Warnings within their medication database, the warnings can be provided to the physician during the prescription process where they are most needed.
In the last several years that have been more and more EMR entrants into the ambulatory marketplace. As part of the development of these products they have been required to include drug information as part of their clinical decision support solution. Lately there have been more requests to provide this drug and medicine information by way of web services calls rather than embedding the data directly into the product. Often times there might be limitations on the EMR's development team and accessing this drug information through web services call could be the simpler solution.
Lexicomp recently released web services calls for drug information that would cover Meaningful Use Stage 1. So for EMRs in the development stage looking for:
In the last two years Lexicomp has quickly become a major provider of drug information to EMR companies for clinical decision support. Many of the new EMRs hitting the market are using Lexicomp medicine information for drug interactions, dose range checking, therapeutic dosages, adverse drug advents, electonic eprescring, and more. Lexi-Data has become the popular choice based on top quality information, unparalleled customer service, state-of-the-art data structure and top-notch APIs. Now something new!!
Lexi-Data has introduced a new structure which allows for the customization of Black Boxed Warning to reduce alert fatigue, yet at the same time delivers the warning to the person who needs it most. This information structure is new and as far as we know not available elsewhere.
API and Database Features:
Incorporates not only the BBW as published within the package insert, but also pulls contextual or supporting information as written by Lexicomp clinical experts
Each summary is broken down and tagged as separate messages / instructions
Each message is paired to a recipient user category – this allow for differentiating where in the workflow of an EMR the message may be displayed
Can be filtered for a more specific and targeted set of messages to clinician/recipient groups, as defined for their site
This is terrific stuff. So for anyone developing drug interaction software or eprescribing modules, this is something you will want to look into.
EMR vendors are not the only ones rapidly deploying clinical decision support systems to healthcare providers. Dental professionals are demanding that their practice management systems overcome massive development hurdles in order to comply with Meaningful Use standards.
There is a buzz in the dental technology community about Meaningful Use and incorporating more clinical decision support into the practice management system workflow. If you are searching for the best dental specific drug database to integrate into your dental EMR, turn to Lexicomp. There are very few suppliers of drug data within the dental market and even fewer still that are easy to work with. And if you are looking for an easy-to-use, out-of-the-box ePrescribing tool, trust our partner DoseSpot to deliver the solution. What do all of these companies have in common? They are easy to work with and provide you with the ability to get to the market fast!
Don't wait to the end of your development process to worry about: dose range checking, pediatric dosing, drug calculators, medicine interactions, dosage precautions, clinical guidelines, drug interaction software, duplicate therapy, drug classifications, generic drug names, drug nomenclature and more. These are critical paths for a dental EMR build. But it's not just about the information. It's about who you select as your partner and who has seamless API's which makes your development easier.
You owe it to your product and your customer to make the right choice.
One of the key reasons that clinicians are frustrated with decision support related to drug interaction software is the potential for alert fatigue. Clinicans do not want to be messaged regarding dosage precautions related to an interaction which has already been recognized and addressed. It is particularly important in the era of electronic prescribing to engineer systems which can present the appropriate information to the appropriate person. Systems need to recognize whether an individual has previously addressed the issue, rather than simply blindly alerting to the presence of two medications within the medicine list. A collaborative effort between drug database providers and application vendors is needed, and discussions to improve the quality of alerts, while decreasing the quantity, are moving forward. These will greatly improve satisfaction with these tools.
If you are in pediatrics you are most likely familiar with the Pediatric Dosage Handbook or Pediatric & Neonatal Lexi-Drugs by Lexicomp. If you are not familiar with these resources I would highly recommend looking into these as many consider this information as the "bible" in safe pediatric dosing. Now that Meaningful Use has been introduced and the larger overall concept of clinical decsion support and integration, Lexicomp has taken this key content and made it available as a database accessed through APIs.
Now that more and more clinical decision support resources are being integrated into the workflow, Lexicomp has invested the resources to be able to offer healthcare applications like EMR, CPOE, etc., a comprehensive database that can easily be implemented for pediatric speicific dosing and drug information, all right within the workflow. The content from Lexicomp's pediatric information can be implemented to build pediatric dosing checks as well as a pediatric dosage calculator to ensure that pediatric and neonatal patients receive safe, accurate dosing and treatment.
So wether you are a clinician or you are an EMR developer this information is a must have and important. Clinicians can benefit from Lexicomp's products the best way they see fit. Subscribing to our print or subscription based references or by having your EMR implement this Lexi-Data, this information cna be implemented right within your workflow.
Many universities and institutions are now expressing an interest in a standardized drug database. They are in search of a high quality, dependable database that helps their academic department build a reliable model to determine pharmaceutical outcomes. Lexicomp is often the preferred choice.
Whether the researcher is in need of a drug reference database for clinical decision support, for dosage administration, patient education material, drug classifications (brand or generic), adverse drug events, drug-drug interaction, drug-allergy interaction, more and more academics are coming to Lexicomp to secure their drug database information. Check out this page for more information.
Powered by Compendium